Open original FDA record ↗Recall record
- FDA identifier
- Z-2310-2010
- Company in FDA record
- Genzyme Corporation
- FDA classification date
- Aug 28, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Revised Labeling of Carticel Essentials Kit clarifies the non-sterile packaging of the outer clear plastic tray which should not be opened in the sterile field.
Source facts
- Action
- Genzyme notiifed physicians with the Dear Doctor letter on July 13, 2010 via UPS Ground delivery. The letter informed healthcare workers of the recent incidents and advise them to heed the Essentials Kit label and exercise proper handling of the Kit.. A fax return form will be provided for the physician to sign and return to Genzyme to acknowledge receipt of the notification. Contact Genzyme Medical Information at 800-453-6948, option #3 for any additional information or contact your Genzyme sales representative with any questions.
- Initiated
- 2010-07-13
- Root cause
- Labeling design
- Terminated
- 2012-01-30
- Distribution
- Nationwide
- Recall number
- Z-2310-2010
- Recall status
- Terminated
- CDRH record ID
- 92974
- FDA classified
- 2010-08-28
- Recall event number
- 56218